share_log

Cantor Fitzgerald Maintains Overweight on Portage Biotech, Lowers Price Target to $11

Benzinga ·  Aug 1, 2023 23:26

Cantor Fitzgerald analyst Li Watsek maintains Portage Biotech (NASDAQ:PRTG) with a Overweight and lowers the price target from $16 to $11.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment